531 MVX-ONCO-1: First in man, Phase I clinical trial combining encapsulation cell technology and irradiated autologous tumor cells for personalized cell-based immunotherapy. Safety, feasibility and clinical outcome results. (September 2015) - Migliorini, D.; Vernet, R.; Belkouch, M.C.; Luy, P.; Blaser, S.; Ancrenaz, V.; Blazek, N.; Grandjean, N.; Wasem, J.; Janin, B.; Harboe-Schmidt, P.; Grogg, J.; et al.